惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

J
Java Code Geeks
Hugging Face - Blog
Hugging Face - Blog
博客园_首页
爱范儿
爱范儿
罗磊的独立博客
美团技术团队
Jina AI
Jina AI
量子位
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
酷 壳 – CoolShell
酷 壳 – CoolShell
有赞技术团队
有赞技术团队
V
V2EX
阮一峰的网络日志
阮一峰的网络日志
小众软件
小众软件
IT之家
IT之家
雷峰网
雷峰网
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
博客园 - 司徒正美
大猫的无限游戏
大猫的无限游戏
博客园 - 聂微东
月光博客
月光博客
人人都是产品经理
人人都是产品经理
博客园 - 三生石上(FineUI控件)

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call ...
2026-05-12 · via All Articles on Seeking Alpha

Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call May 11, 2026 4:30 PM EDT

Company Participants

Tram Bui - Head of Investor Relations & Corporate Communications
Helen Torley - President, CEO & Director
David Ramsay - Interim Chief Financial Officer

Conference Call Participants

Jason Butler - Citizens JMP Securities, LLC, Research Division
Brendan Smith - TD Cowen, Research Division
Mohit Bansal - Wells Fargo Securities, LLC, Research Division
David Risinger - Leerink Partners LLC, Research Division
Sean Laaman - Morgan Stanley, Research Division
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division
Jessica Fye - JPMorgan Chase & Co, Research Division
Michael DiFiore - Evercore ISI Institutional Equities, Research Division

Presentation

Operator

Good afternoon. My name is Melissa, and I will be your conference operator today. At this time, I would like to welcome everyone to Halozyme's First Quarter 2026 Financial and Operating Results Conference Call. Please note, this event is being recorded.

I will now turn the call over to Tram Bui, Halozyme's Vice President of Investor Relations and Corporate Communications. Please go ahead.

Tram Bui
Head of Investor Relations & Corporate Communications

Thank you, operator. Good afternoon, and welcome to our First Quarter 2026 Financial and Operating Results conference call. In addition to the press release issued today, after the market closed, you can find a supplementary slide presentation that will be referenced during today's call in the Investor Relations section of our website. Leading the call will be Dr. Helen Torley, Halozyme's President and Chief Executive Officer, who will provide an update on our business; and David Ramsay, our Interim Chief Financial Officer, will review our financial results as well as our outlook.

On today's call, we will be making forward-looking statements as outlined on Slide 2. I would also refer you to our SEC filings for a full list of risks and uncertainties. During the call, both